Bartels Legionella urinary antigen kits may contain particulate matter
Bartels ELISA Legionella Urinary Antigen kits are being recalled because two lots have the potential to contain particulate matter. 968 kits are affected.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall over possible particulate matter in a laboratory test kit, with no incorrect result or clinical consequence stated.
Plain-English summary
The Bartels ELISA Legionella Urinary Antigen test kit, model number B1029-440, UDI-DI 05391516744065, an in vitro diagnostic test for the presumptive diagnosis of past or current Legionnaires' Disease, is being recalled. The action covers 968 kits from lots 065 and 066.
The stated reason is the potential for the kits to contain particulate matter. The FDA classified the action as Class II. The source does not describe a resulting result or clinical consequence.
Distribution was worldwide, including nationwide in the United States in Maryland and Utah.
Laboratories should identify affected stock using the model number, UDI-DI and lot numbers above and follow the instructions issued by the manufacturer.
The recalled product
- Product
- Bartels ELISA Legionella Urinary Antigen. Model Number: B1029-440. In Vitro Diagnostic test kit for the presumptive diagnosis of past or current Legionnaires Disease.
- Manufacturer
- Trinity Biotech USA
- Affected units
- 968
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Model Number: B1029-440. UDI-DI: 05391516744065. Lot Numbers: 065 and 066
Distribution
Related recalls
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereAmerican Regent Recalls Nitroglycerin Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereFDA Recalls Nicardipine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26